Compare NMFC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NMFC | RAPP |
|---|---|---|
| Founded | 2010 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 972.8M | 1.2B |
| IPO Year | 2011 | 2024 |
| Metric | NMFC | RAPP |
|---|---|---|
| Price | $9.17 | $26.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $10.00 | ★ $47.80 |
| AVG Volume (30 Days) | ★ 796.7K | 417.4K |
| Earning Date | 02-25-2026 | 11-06-2025 |
| Dividend Yield | ★ 14.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $340,877,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.78 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.84 | $6.43 |
| 52 Week High | $12.05 | $42.27 |
| Indicator | NMFC | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 42.60 |
| Support Level | $9.02 | $26.30 |
| Resistance Level | $9.31 | $28.10 |
| Average True Range (ATR) | 0.17 | 1.80 |
| MACD | 0.01 | -0.37 |
| Stochastic Oscillator | 37.33 | 20.07 |
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.